|
Real-time
Euronext Paris
10:49:44 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 0.8780 EUR | -0.68% |
|
+11.56% | -8.54% |
| 09-08 | Transgene Expands ProBioGen Partnership With Additional License | MT |
| 09-03 | Transgene jumps 20% on positive cancer vaccine data in early trial | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TRANSGENE | Bio Therapeutic Drugs | -0.68% | +11.56% | -8.54% | -19.45% | -66.99% | 282M |  | |  |
- Stock Market
- Stocks
- TNG Stock
- Charts Transgene
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
